Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: A longitudinal seroprevalence study at a university hospital in Catalonia, Spain

with No hi ha comentaris
  • Micó, M., Trapé, J., González-García, L., Trujillo-Isern, G., González-Fernández, C., López-Madueño, J., Bérgamo, S., Pérez-Vidal, R., Flor, A., Martínez-Montero, R., Rives, J., Arnau, A., & Fàbrega, A. (2026). Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: A longitudinal seroprevalence study at a university hospital in Catalonia, Spain. BMC Infectious Diseases, 26(1), 522. https://doi.org/10.1186/s12879-026-12796-8

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *